Blood Res.  2013 Sep;48(3):230-233. 10.5045/br.2013.48.3.230.

Waldenstrom's macroglobulinemia presenting with lytic bone lesions: a rare presentation

• Pujani M
• Kushwaha S
• Sethi N
• Beniwal A
• Shukla S

• KMID: 2270713
• DOI: http://doi.org/10.5045/br.2013.48.3.230

Abstract

No abstract available.

MeSH Terms

Waldenstrom Macroglobulinemia

Figure

• 

  Fig. 1 Photomicrograph showing hypercellular bone marrow smears with the presence of mostly bare nuclei, few lymphoid cells, and plasmacytic cells (Wright's stain, ×1,000).

• 

  Fig. 2 Photomicrograph showing hypercellular marrow with diffuse infiltration by lymphoid cells, plasmacytoid lymphocytes, a few plasma cells, and mast cells (hematoxylin and eosin stain, ×1,000); inset photomicrograph showing strong cytoplasmic positivity for CD20 in the majority of the lymphoid cells (immunohistochemical stain for CD20, ×400).

Reference

1. Swerdlow SH, Campo E, Harris NL, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon, France: IARC Press;2008. p. 194–195.

2. Owen RG, Treon SP, Al-Katib A, et al. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. Semin Oncol. 2003; 30:110–115. PMID: 12720118.

3. Leb L, Grimes ET, Balogh K, Merritt JA Jr. Monoclonal macroglobulinemia with osteolytic lesions: a case report and review of the literature. Cancer. 1977; 39:227–231. PMID: 401675.

4. Krausz Y, Zlotnick A. Macroglobulinemia of Waldenstrom associated with severe osteolytic lesions. Acta Haematol. 1977; 58:307–311. PMID: 413307.

5. Marks MA, Tow DE, Jay M. Bone scanning in Waldenstrom's macroglobulinemia. J Nucl Med. 1985; 26:1412–1414. PMID: 3934348.

6. Schlesinger N, Neustadter L, Schumacher HR. Lytic bone lesions as a prominent feature in Waldenstrom's macroglobulinemia. J Clin Rheumatol. 2000; 6:150–153. PMID: 19078464.

7. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood. 1997; 89:3909–3918. PMID: 9166827.

8. Owen RG, Parapia LA, Higginson J, et al. Clinicopathological correlates of IgM paraproteinemias. Clin Lymphoma. 2000; 1:39–43. PMID: 11707811.

9. Dimopoulos MA, Panayiotidis P, Moulopoulos LA, Sfikakis P, Dalakas M. Waldenstrom's macroglobulinemia: clinical features, complications, and management. J Clin Oncol. 2000; 18:214–226. PMID: 10623712.

10. Dimopoulos MA, Hamilos G, Zervas K, et al. Survival and prognostic factors after initiation of treatment in Waldenstrom's macroglobulinemia. Ann Oncol. 2003; 14:1299–1305. PMID: 12881396.

11. Dimopoulos MA, Kyle RA, Anagnostopoulos A, Treon SP. Diagnosis and management of Waldenstrom's macroglobulinemia. J Clin Oncol. 2005; 23:1564–1577. PMID: 15735132.

12. Gertz MA, Fonseca R, Rajkumar SV. Waldenstrom's macroglobulinemia. Oncologist. 2000; 5:63–67. PMID: 10706651.

13. Ju KT, Bang SM, Song KS, et al. A case of Waldenstrom's macroglobulinemia presented as a compression fracture of spine. Korean J Hematol. 2001; 36:257–261.

14. Gad A, Willen R, Carlen B, Gyland F, Wickander M. Duodenal involvement in Waldenstrom's macroglobulinemia. J Clin Gastroenterol. 1995; 20:174–176. PMID: 7769205.

15. Yasui O, Tukamoto F, Sasaki N, et al. Malignant lymphoma of the transverse colon associated with macroglobulinemia. Am J Gastroenterol. 1997; 92:2299–2301. PMID: 9399775.